SARAH RANSOM: Open Payments
NPI 1437888237 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 47 payments from 16 companies in 2025. Trend: 2023 $763 · 2024 $878 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $270 |
| Otsuka America Pharmaceutical, Inc. | 6 | $114 |
| Indivior Inc. | 4 | $93 |
| Lundbeck LLC | 4 | $68 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| Braeburn Inc. | 2 | $65 |
| Alkermes, Inc. | 2 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 2 | $51 |
Products named: VRAYLAR, REXULTI, SUBLOCADE, FANAPT, BRIXADI, ARISTADA, SPRAVATO, INGREZZA.
Industry payments across NV — which companies pay providers there.
